2 most recent filings and news items mentioning MDAI. Updated every 60 seconds.
RegulatoryJun 1, 2026Positive
Spectral AI announced FDA De Novo Classification for its DeepView System for burn wound assessment, authorizing commercial distribution in the U.S. The company also secured $31.7 million in BARDA funding and elected its board of directors at its annual stockholder meeting.
View filing at SEC.gov →
RegulatoryMay 26, 2026Positive
Spectral AI's DeepView System, an AI-powered medical device for burn wound assessment, received FDA De Novo classification, authorizing commercial distribution in the U.S. The clearance enables the company to commercialize its non-invasive diagnostic technology across burn center
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.